Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
University of Ottawa
$120,000.00
Functional and integrative omics analysis of xCT inactivation in cardiac ischemia reperfusion injury
EF 2025-26
Résumé
Heart failure is a serious and often deadly condition that affects more than 750,000 Canadians. The most common cause is a blockage in one of the heart's arteries, which cuts off blood flow and deprives the heart of oxygen and nutrients. If this lack of blood flow lasts too long, parts of the heart can become permanently damaged. Restoring blood flow is essential but can also cause further harm through a process called ischemia reperfusion injury (IRI). When blood and oxygen suddenly return, the heart experiences a burst of stress that can trigger cell death. One type of cell death involved in this process is ferroptosis. Ferroptosis occurs when harmful oxygen-based molecules, known as reactive oxygen species (ROS), build up faster than the heart's natural antioxidant defense systems can remove them. During reperfusion, the sudden surge of oxygen causes ROS to react with important components of the cell like DNA and proteins, resulting in serious damage. Normally, antioxidants like glutathione keep ROS in check, but during reperfusion ROS levels rise so quickly the heart's protective systems are overwhelmed. A key protein called xCT helps make glutathione by importing an essential ingredient called cystine into cells. When xCT doesn't work properly, cells run out of glutathione more quickly, making them vulnerable to ferroptosis. On the other hand, increasing xCT activity may help protect the heart. In this project we will study how reducing xCT function affects heart injury in a mouse model of ischemia-reperfusion. We will also measure changes in the heart's proteins and metabolites to understand how xCT loss disrupts broader signaling networks in heart cells. We expect that lower xCT activity will worsen heart injury and cause major changes in how the heart manages stress.
Programme
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
559067
Name
McIlroy Ella C
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Functional and integrative omics analysis of xCT inactivation in cardiac ischemia reperfusion injury
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Bioinformatics; Heart Failure; Metabolism; Oxidative Stress; Proteomics
Abstract
Heart failure is a serious and often deadly condition that affects more than 750,000 Canadians. The most common cause is a blockage in one of the heart's arteries, which cuts off blood flow and deprives the heart of oxygen and nutrients. If this lack of blood flow lasts too long, parts of the heart can become permanently damaged. Restoring blood flow is essential but can also cause further harm through a process called ischemia reperfusion injury (IRI). When blood and oxygen suddenly return, the heart experiences a burst of stress that can trigger cell death. One type of cell death involved in this process is ferroptosis. Ferroptosis occurs when harmful oxygen-based molecules, known as reactive oxygen species (ROS), build up faster than the heart's natural antioxidant defense systems can remove them. During reperfusion, the sudden surge of oxygen causes ROS to react with important components of the cell like DNA and proteins, resulting in serious damage. Normally, antioxidants like glutathione keep ROS in check, but during reperfusion ROS levels rise so quickly the heart's protective systems are overwhelmed. A key protein called xCT helps make glutathione by importing an essential ingredient called cystine into cells. When xCT doesn't work properly, cells run out of glutathione more quickly, making them vulnerable to ferroptosis. On the other hand, increasing xCT activity may help protect the heart. In this project we will study how reducing xCT function affects heart injury in a mouse model of ischemia-reperfusion. We will also measure changes in the heart's proteins and metabolites to understand how xCT loss disrupts broader signaling networks in heart cells. We expect that lower xCT activity will worsen heart injury and cause major changes in how the heart manages stress.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
McIlroy, Ella C
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~